Hyperexpression of recombinant CFTR in heterologous cells alters its physiological properties
- 1 February 1998
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 274 (2) , C310-C318
- https://doi.org/10.1152/ajpcell.1998.274.2.c310
Abstract
We investigated whether high levels of expression of the cystic fibrosis transmembrane conductance regulator (CFTR) would alter the functional properties of newly synthesized recombinant proteins. COS-7, CFPAC-1, and A549 cells were intranuclearly injected with a Simian virus 40-driven pECE-CFTR plasmid and assayed for halide permeability using the 6-methoxy-N-(3-sulfopropyl)quinolinium fluorescent probe. With increasing numbers of microinjected pECE-CFTR copies, the baseline permeability to halide dose dependently increased, and the response to adenosine 3′,5′-cyclic monophosphate (cAMP) stimulation decreased. In cells hyperexpressing CFTR, the high level of halide permeability was reduced when a cell metabolism poisoning cocktail was applied to decrease intracellular ATP and, inversely, was increased by orthovanadate. In CFPAC-1 cells investigated with the patch-clamp technique, CFTR hyperexpression led to a time-independent nonrectifying chloride current that was not sensitive to cAMP stimulation. CFPAC-1 cells hyperexpressing CFTR exhibited no outward rectifying chloride current nor inward rectifying potassium current either spontaneously or under cAMP stimulation. We conclude that hyperexpression of recombinant CFTR proteins modifies their properties inasmuch as 1) CFTR channels are permanently activated and not susceptible to cAMP regulation and 2) they lose their capacity to regulate heterologous ionic channels.Keywords
This publication has 32 references indexed in Scilit:
- Current status of CF gene therapyTrends in Genetics, 1996
- CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATPCell, 1995
- Gene Therapy for Cystic Fibrosis Using E1-Deleted Adenovirus: A Phase I Trial in the Nasal Cavity. University of North Carolina at Chapel Hill, Chapel Hill, North CarolinaHuman Gene Therapy, 1994
- Coupling of CFTR Cl− channel gating to an ATP hydrolysis cycleNeuron, 1994
- Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTRHuman Molecular Genetics, 1993
- Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)Cell, 1992
- Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channelCell, 1991
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989
- Quantitation of the volume of liquid injected into cells by means of pressureExperimental Cell Research, 1989
- Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 1986